Search - tctmd.com

Displaying 361 - 380 of 662

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2016

Shelley Wood

September 30, 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

News Conference News PCR London Valves 2016

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Shelley Wood

September 20, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

News Daily News

Mortality Risk High in TAVR Patients Who Require Mechanical Circulatory Support

Todd Neale

August 25, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

Presentation

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Presenter: Abdul-Jawad Altisent

August 16, 2016

News Daily News

Antithrombotic Cocktail Fails to Provide Benefit, Increases Bleeding in A-Fib Patients Undergoing TAVR

Yael L. Maxwell

August 16, 2016

News Industry News

EDWARDS INTUITY Elite Rapid Deployment Valve Receives FDA Approval

August 15, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2016

Shelley Wood

July 28, 2016

News Daily News

High Rates of Upper GI Bleeding After TAVR Pose Questions for Antithrombotics and TEE

Yael L. Maxwell

July 22, 2016

News Daily News

Combining Off-Pump CABG and Transaortic TAVR May Be an Option in Some Cases

Todd Neale

July 14, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

Presentation TVT 2016

Aspects of Managing the Coronary Artery Preservation: Case Presentation (Two Examples)

Presenter: Susheel Kodali

June 18, 2016

Presentation TVT 2016

Cardioband for Tricuspid Regurgitation

Presenter: Francesco Maisano

June 17, 2016

Presentation TVT 2016

TVT 1011: High-Risk TAVR in a Failed Freestyle Valve With Low Coronary Height

Presenter: Ashkan Karimi, MD

June 17, 2016

Presentation TVT 2016

An Update on Subclinical Bioprosthetic Leaflet Thickening and Thrombosis: Possible Effects on TAVR Durability

Presenter: Raj Makkar

June 17, 2016

Presentation TVT 2016

The Incidence, Diagnosis, Impact, and Treatment of Valve Thrombosis After TAVR

Presenter: Azeem Latib

June 17, 2016

Presentation TVT 2016

The Sentinel US Pivotal Clinical Trial Design

Presenter: Susheel Kodali

June 17, 2016

Advertisement

TCTMD’s Top 10 Most Popular Stories for September 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

TCTMD’s Top 10 Most Popular Stories for August 2016

Mortality Risk High in TAVR Patients Who Require Mechanical Circulatory Support

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Warfarin and Antiplatelet Therapy vs Warfarin Alone for Treating Patients with A-fib Undergoing TAVR

Antithrombotic Cocktail Fails to Provide Benefit, Increases Bleeding in A-Fib Patients Undergoing TAVR

EDWARDS INTUITY Elite Rapid Deployment Valve Receives FDA Approval

TCTMD’s Top 10 Most Popular Stories for July 2016

High Rates of Upper GI Bleeding After TAVR Pose Questions for Antithrombotics and TEE

Combining Off-Pump CABG and Transaortic TAVR May Be an Option in Some Cases

TCTMD’s Top 10 Most Popular Stories for June 2016

Aspects of Managing the Coronary Artery Preservation: Case Presentation (Two Examples)

Cardioband for Tricuspid Regurgitation

TVT 1011: High-Risk TAVR in a Failed Freestyle Valve With Low Coronary Height

An Update on Subclinical Bioprosthetic Leaflet Thickening and Thrombosis: Possible Effects on TAVR Durability

The Incidence, Diagnosis, Impact, and Treatment of Valve Thrombosis After TAVR

The Sentinel US Pivotal Clinical Trial Design

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content